Trial Profile
A Multicenter, Double-blind, Randomized, Placebo-controlled Parallel Groups Study Comparing the Efficacy and Safety of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.; Organon; Schering-Plough
- 28 Apr 2010 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
- 12 Jan 2007 New trial record.